Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, BHVN, INSM, KURA, ITCI, and represent 32.12% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: UNH (+$75M), ITCI (+$42M), BHVN (+$42M), AAPL (+$39M), SYY (+$37M), CTNM (+$36M), INSM (+$33M), ERAS (+$33M), MCD (+$28M), SPY (+$27M).
- Started 9 new stock positions in GLUE, EXAS, SYY, FIVE, CTNM, MCD, ABEO, ERAS, TSLA.
- Reduced shares in these 10 stocks: QQQ (-$87M), ARGX (-$48M), CI (-$44M), MCK (-$32M), VZ (-$24M), BCYC (-$23M), FATE (-$19M), HLT (-$17M), , SBUX (-$16M).
- Sold out of its positions in AKLI, ARGX, BCYC, COGT, FATE, GPN, HLT, QQQ, KRRO, CRM. SBUX, TERN.
- Suvretta Capital Management was a net buyer of stock by $198M.
- Suvretta Capital Management has $2.7B in assets under management (AUM), dropping by 1.10%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 98 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 10.0 | $272M | +11% | 500k | 544.22 |
|
| Biohaven (BHVN) | 6.6 | $181M | +29% | 5.2M | 34.71 |
|
| Insmed Com Par $.01 (INSM) | 6.2 | $169M | +24% | 2.5M | 67.00 |
|
| Kura Oncology (KURA) | 5.3 | $146M | 7.1M | 20.59 |
|
|
| Intra Cellular Therapies (ITCI) | 3.9 | $107M | +63% | 1.6M | 68.49 |
|
| Arcutis Biotherapeutics (ARQT) | 3.4 | $93M | +27% | 10M | 9.30 |
|
| Ultragenyx Pharmaceutical (RARE) | 3.1 | $85M | +22% | 2.1M | 41.10 |
|
| Meta Platforms Cl A (META) | 3.1 | $84M | -3% | 167k | 504.22 |
|
| Arcellx Common Stock (ACLX) | 3.1 | $84M | -2% | 1.5M | 55.19 |
|
| UnitedHealth (UNH) | 3.0 | $82M | +967% | 162k | 509.26 |
|
| Apple (AAPL) | 2.8 | $77M | +105% | 363k | 210.62 |
|
| Amazon (AMZN) | 2.5 | $69M | 356k | 193.25 |
|
|
| 89bio (ETNB) | 2.4 | $64M | +27% | 8.0M | 8.01 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 2.2 | $61M | +6% | 351k | 173.81 |
|
| Advanced Micro Devices (AMD) | 2.1 | $56M | 346k | 162.21 |
|
|
| Anthem (ELV) | 1.8 | $50M | +79% | 91k | 541.86 |
|
| Kalvista Pharmaceuticals (KALV) | 1.8 | $49M | 4.2M | 11.78 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 1.8 | $49M | -17% | 1.9M | 26.37 |
|
| Microsoft Corporation (MSFT) | 1.7 | $47M | +31% | 104k | 446.95 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.7 | $45M | +37% | 5.2M | 8.70 |
|
| Apollo Global Mgmt (APO) | 1.5 | $42M | -4% | 355k | 118.07 |
|
| At&t (T) | 1.5 | $42M | -8% | 2.2M | 19.11 |
|
| SYSCO Corporation (SYY) | 1.4 | $37M | NEW | 521k | 71.39 |
|
| Contineum Therapeutics Cl A (CTNM) | 1.3 | $36M | NEW | 2.1M | 17.61 |
|
| Coca-Cola Company (KO) | 1.3 | $36M | +2% | 561k | 63.65 |
|
| Goldman Sachs (GS) | 1.3 | $35M | -29% | 78k | 452.32 |
|
| Oracle Corporation (ORCL) | 1.3 | $35M | +24% | 245k | 141.20 |
|
| Ge Aerospace Com New (GE) | 1.2 | $33M | 205k | 158.97 |
|
|
| Erasca (ERAS) | 1.2 | $33M | NEW | 14M | 2.36 |
|
| CRH Ord (CRH) | 1.2 | $32M | +28% | 432k | 74.98 |
|
| Arrivent Biopharma (AVBP) | 1.2 | $32M | +9% | 1.7M | 18.55 |
|
| McDonald's Corporation (MCD) | 1.0 | $28M | NEW | 110k | 254.84 |
|
| Ferguson SHS | 1.0 | $28M | -14% | 145k | 193.65 |
|
| Tesla Motors (TSLA) | 1.0 | $27M | NEW | 135k | 197.88 |
|
| Verizon Communications (VZ) | 0.9 | $25M | -48% | 610k | 41.24 |
|
| Chipotle Mexican Grill (CMG) | 0.9 | $25M | +4900% | 399k | 62.65 |
|
| Pepgen (PEPG) | 0.9 | $24M | 1.5M | 15.96 |
|
|
| Prokidney Corp Class A Ord Shs (PROK) | 0.8 | $23M | +141% | 9.3M | 2.46 |
|
| Sutro Biopharma (STRO) | 0.8 | $23M | +33% | 7.7M | 2.93 |
|
| Boston Scientific Corporation (BSX) | 0.7 | $19M | -16% | 252k | 77.01 |
|
| Pinterest Cl A (PINS) | 0.7 | $18M | +3% | 410k | 44.07 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $17M | +70% | 4.9M | 3.50 |
|
| Fulcrum Therapeutics (FULC) | 0.6 | $16M | -10% | 2.5M | 6.20 |
|
| Abeona Therapeutics Com New (ABEO) | 0.6 | $16M | NEW | 3.7M | 4.24 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.5 | $15M | 957k | 15.23 |
|
|
| Johnson & Johnson (JNJ) | 0.5 | $13M | 90k | 146.16 |
|
|
| Benitec Biopharma Com New (BNTC) | 0.4 | $12M | +728% | 1.7M | 6.99 |
|
| Immatics SHS (IMTX) | 0.4 | $11M | 947k | 11.62 |
|
|
| Sanofi Sponsored Adr (SNY) | 0.4 | $10M | 211k | 48.52 |
|
|
| Inflarx Nv (IFRX) | 0.4 | $10M | 5.7M | 1.74 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $9.9M | NEW | 2.7M | 3.74 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $9.1M | +15% | 38k | 243.00 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.2 | $5.8M | 75k | 77.92 |
|
|
| Marinus Pharmaceuticals Com New (MRNS) | 0.2 | $4.5M | -25% | 3.8M | 1.17 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.2 | $4.4M | 268k | 16.25 |
|
|
| Kezar Life Sciences (KZR) | 0.2 | $4.3M | 7.2M | 0.60 |
|
|
| Danaher Corporation (DHR) | 0.2 | $4.1M | 16k | 249.85 |
|
|
| Thermo Fisher Scientific (TMO) | 0.1 | $4.0M | 7.3k | 553.00 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $4.0M | NEW | 94k | 42.25 |
|
| Elanco Animal Health (ELAN) | 0.1 | $3.7M | -50% | 254k | 14.43 |
|
| Abbott Laboratories (ABT) | 0.1 | $3.5M | 34k | 103.91 |
|
|
| Gilead Sciences (GILD) | 0.1 | $3.5M | 51k | 68.61 |
|
|
| Kenvue (KVUE) | 0.1 | $3.1M | 172k | 18.18 |
|
|
| Molecular Partners Ads (MOLN) | 0.1 | $2.9M | 400k | 7.23 |
|
|
| AmerisourceBergen (COR) | 0.1 | $2.8M | 13k | 225.30 |
|
|
| Mettler-Toledo International (MTD) | 0.1 | $2.7M | 2.0k | 1397.59 |
|
|
| Spyre Therapeutics Com New (SYRE) | 0.1 | $2.5M | -33% | 107k | 23.51 |
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.3M | 5.2k | 444.85 |
|
|
| Tourmaline Bio (TRML) | 0.1 | $1.6M | 125k | 12.86 |
|
|
| Cigna Corp (CI) | 0.1 | $1.6M | -96% | 4.8k | 330.57 |
|
| Avantor (AVTR) | 0.1 | $1.5M | 72k | 21.20 |
|
|
| Iqvia Holdings (IQV) | 0.1 | $1.5M | 7.2k | 211.44 |
|
|
| Stryker Corporation (SYK) | 0.1 | $1.5M | 4.4k | 340.25 |
|
|
| Medtronic SHS (MDT) | 0.1 | $1.4M | 18k | 78.71 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 0.0 | $1.2M | 47k | 24.78 |
|
|
| Natera (NTRA) | 0.0 | $1.1M | -58% | 10k | 108.29 |
|
| McKesson Corporation (MCK) | 0.0 | $1.1M | -96% | 1.8k | 584.04 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $1.1M | 31k | 34.65 |
|
|
| Edwards Lifesciences (EW) | 0.0 | $1.0M | 11k | 92.37 |
|
|
| Hca Holdings (HCA) | 0.0 | $1.0M | 3.2k | 321.28 |
|
|
| CVS Caremark Corporation (CVS) | 0.0 | $1.0M | 17k | 59.06 |
|
|
| Waters Corporation (WAT) | 0.0 | $914k | 3.2k | 290.12 |
|
|
| Illumina (ILMN) | 0.0 | $911k | 8.7k | 104.38 |
|
|
| Five Below (FIVE) | 0.0 | $833k | NEW | 7.6k | 108.97 |
|
| Humana (HUM) | 0.0 | $729k | 2.0k | 373.65 |
|
|
| Dex (DXCM) | 0.0 | $667k | 5.9k | 113.38 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $647k | 5.0k | 129.63 |
|
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $523k | 5.5k | 95.47 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $515k | 11k | 47.66 |
|
|
| ResMed (RMD) | 0.0 | $458k | 2.4k | 191.42 |
|
|
| Morgan Stanley Com New (MS) | 0.0 | $448k | -39% | 4.6k | 97.19 |
|
| Zimmer Holdings (ZBH) | 0.0 | $354k | 3.3k | 108.53 |
|
|
| Steris Shs Usd (STE) | 0.0 | $336k | 1.5k | 219.54 |
|
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.0 | $270k | -97% | 75k | 3.60 |
|
| Baxter International (BAX) | 0.0 | $267k | 8.0k | 33.45 |
|
|
| Align Technology (ALGN) | 0.0 | $266k | 1.1k | 241.43 |
|
|
| Charles River Laboratories (CRL) | 0.0 | $209k | 1.0k | 206.58 |
|
|
| Revance Therapeutics (RVNC) | 0.0 | $150k | -96% | 58k | 2.57 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2024 Q2 filed Aug. 14, 2024
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022
- Suvretta Capital Management 2021 Q3 restated filed Nov. 16, 2021
- Suvretta Capital Management 2021 Q3 filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q3 amended filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q2 filed Aug. 16, 2021
- Suvretta Capital Management 2021 Q1 filed May 17, 2021
- Suvretta Capital Management 2020 Q4 filed Feb. 16, 2021